Random Noise Stimulation to Enhance Cortical Drive & Improve Hand Function
NCT ID: NCT04777149
Last Updated: 2022-10-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
19 participants
INTERVENTIONAL
2021-04-12
2022-08-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Conditioning Neural Circuits to Improve Upper Extremity Function
NCT02611375
Enhancing Corticospinal Excitability to Improve Functional Recovery
NCT03237091
Improving Motor Function After Spinal Cord Injury
NCT01915095
Nerve Transfer After Spinal Cord Injuries
NCT01714349
Rebuilding Inter-limb Transfer in Cervical SCI
NCT06440538
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
transcranial Random Noise Stimulation (tRNS)
Participants in this group will receive a combined intervention (3 days of tRNS during functional task practice and 3 days of sham-stimulation during functional task practice).
transcranial Random Noise Stimulation (tRNS)
Two electrodes will be placed over the targeted areas on participant's head. A current of random frequency and intensity will be delivered. TRNS will be applied during the first 20 min of functional task practice.
sham-stimulation
Two electrodes will be placed over the targeted areas on participant's head. A continuous low intensity current will be delivered for 1- 2 min.
transcranial Direct Current Stimulation (tDCS)
Participants in this group will receive a combined intervention (3 days of tDCS during functional task practice and 3 days of sham-stimulation during functional task practice).
transcranial Direct Current Stimulation (tDCS)
Two electrodes will be placed over the targeted areas on participant's head. A continuous low intensity current will be delivered. TDCS will be applied during the first 20 min of functional task practice.
sham-stimulation
Two electrodes will be placed over the targeted areas on participant's head. A continuous low intensity current will be delivered for 1- 2 min.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
transcranial Random Noise Stimulation (tRNS)
Two electrodes will be placed over the targeted areas on participant's head. A current of random frequency and intensity will be delivered. TRNS will be applied during the first 20 min of functional task practice.
transcranial Direct Current Stimulation (tDCS)
Two electrodes will be placed over the targeted areas on participant's head. A continuous low intensity current will be delivered. TDCS will be applied during the first 20 min of functional task practice.
sham-stimulation
Two electrodes will be placed over the targeted areas on participant's head. A continuous low intensity current will be delivered for 1- 2 min.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ASIA Impairment Scale (AIS) classification level: C, D
* Time since injury: ≥ 1 year
* Active intrinsic hand muscles in at least one UE
* Active extrinsic hand muscles in both UE
* Ability to follow multiple step commands
* Ability to communicate pain or discomfort
* Willingness to participate in testing
* Ability to obtain informed consent
Exclusion Criteria
* History of seizures
* History of severe headaches
* Severe contractures of UE that would limit participation in FTP
* Prior tendon or nerve transfer surgery
* Received Botulinum toxin injection in the tested UE in the last 3 months
* Pregnancy
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Craig H. Neilsen Foundation
OTHER
Shepherd Center, Atlanta GA
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anastasia Zarkou, PT,MS,PhD
Role: PRINCIPAL_INVESTIGATOR
Shepherd Center, Atlanta GA
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shepherd Center
Atlanta, Georgia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
762
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.